ARTMS Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 31

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $77.7M

  • Investors
  • 1

ARTMS General Information

Description

Developer of novel radioisotope technology and products designed to enable the high-yield production of diagnostic imaging isotopes. The company's technology facilitates decentralized, cost-effective, and large-scale production of critical medical isotopes such as gallium-68 (68Ga), zirconium-89 (89Zr), technetium-99m (99mTc), and copper-64 (64Cu) using local hospital-based medical cyclotrons, enabling the nuclear medicine industry to control and meet supply chain needs.

Contact Information

Website
www.artms.ca
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 8575 Commerce Court
  • Burnaby, British Columbia V5A 4N5
  • Canada
+1 (604)
Primary Industry
Other Devices and Supplies
Other Industries
Diagnostic Equipment
Other Pharmaceuticals and Biotechnology
Parent Company
Corporate Office
  • 8575 Commerce Court
  • Burnaby, British Columbia V5A 4N5
  • Canada
+1 (604)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ARTMS Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 11-Apr-2024 $77.7M Completed Generating Revenue
4. Grant 02-Mar-2021 Completed Generating Revenue
3. Later Stage VC (Series A) 20-May-2020 Completed Generating Revenue
2. Grant 09-Aug-2019 $1.14M $3M Completed Generating Revenue
1. Early Stage VC 18-Dec-2017 $3M $3M Completed Generating Revenue
To view ARTMS’s complete valuation and funding history, request access »

ARTMS Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel radioisotope technology and products designed to enable the high-yield production of diagnostic imagi
Other Devices and Supplies
Burnaby, Canada
31 As of 2024

Janesville, WI
 

Corvallis, OR
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ARTMS Competitors (5)

One of ARTMS’s 5 competitors is SHINE Technologies, a Private Equity-Backed company based in Janesville, WI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SHINE Technologies Private Equity-Backed Janesville, WI
Northwest Medical Isotopes Venture Capital-Backed Corvallis, OR
NorthStar (Pharmaceuticals) Venture Capital-Backed Beloit, WI
TISSIUM Venture Capital-Backed Paris, France
FluoroPharma Formerly VC-backed Montclair, NJ
You’re viewing 5 of 5 competitors. Get the full list »

ARTMS Patents

ARTMS Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2022551697-A System and method for isolation of gallium-68 Pending 12-Oct-2019
AU-2020364423-A1 Systems and methods of isolation of gallium-68 Active 12-Oct-2019
AU-2020364423-B2 Systems and methods of isolation of gallium-68 Active 12-Oct-2019
AU-2020364423-C1 Systems and methods of isolation of gallium-68 Active 12-Oct-2019
CA-3156951-A1 Systems and methods of isolation of gallium-68 Active 12-Oct-2019 B01D15/1871
To view ARTMS’s complete patent history, request access »

ARTMS Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ARTMS Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Deerfield Management Venture Capital Minority
GF Securities Investment Bank Minority
Quark Venture Venture Capital Minority
Western Economic Diversification Canada Government
To view ARTMS’s complete investors history, request access »

ARTMS FAQs

  • When was ARTMS founded?

    ARTMS was founded in 2013.

  • Where is ARTMS headquartered?

    ARTMS is headquartered in Burnaby, Canada.

  • What is the size of ARTMS?

    ARTMS has 31 total employees.

  • What industry is ARTMS in?

    ARTMS’s primary industry is Other Devices and Supplies.

  • Is ARTMS a private or public company?

    ARTMS is a Private company.

  • What is the current valuation of ARTMS?

    The current valuation of ARTMS is .

  • What is ARTMS’s current revenue?

    The current revenue for ARTMS is .

  • How much funding has ARTMS raised over time?

    ARTMS has raised $22M.

  • Who are ARTMS’s investors?

    Deerfield Management, GF Securities, Quark Venture, and Western Economic Diversification Canada have invested in ARTMS.

  • Who are ARTMS’s competitors?

    SHINE Technologies, Northwest Medical Isotopes, NorthStar (Pharmaceuticals), TISSIUM, and FluoroPharma are competitors of ARTMS.

  • When was ARTMS acquired?

    ARTMS was acquired on 11-Apr-2024.

  • Who acquired ARTMS?

    ARTMS was acquired by Telix Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process